Dexcom CEO Discusses Future Uses for Continuous Glucose Monitors
Dexcom CEO Kevin Sayer discussed potential new applications for continuous glucose monitoring technology during a conversation covered by STAT Health Tech. The newsletter also reported updates on WiSeR and Epic's market share in health technology.
finance.yahoo.comDexcom CEO Kevin Sayer discussed potential future uses for continuous glucose monitoring devices in a conversation reported by STAT Health Tech on May 19, 2026. The newsletter covered takeaways from the exchange along with updates on WiSeR and Epic's market share in the health technology sector.
Sayer addressed possible expansions of CGM technology beyond current diabetes management applications. The discussion took place as part of STAT's coverage of health technology developments.
STAT Health Tech publishes the newsletter twice weekly and covers technology applications in health care.
Key Facts
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.